Company Overview of InCarda Therapeutics, Inc.
Key Executives for InCarda Therapeutics, Inc.
|Grace E. Colon Ph.D.||No Relationships||Chief Executive Officer and President||--|
|Gregory M. Marcus M.D., M.A.S., F.A.C.C., F.A.H.A., F.H.R.S.||3 Relationships||Co-Founder and Chief Medical Officer for Consulting||--|
|John S. Patton Ph.D., MSc, MBA||31 Relationships||Co-Founder and Executive Chairman||68|
|Narsi Rangachari M. Pharm.||No Relationships||Co-Founder and Chief Operating Officer||--|
|Carlos A. Schuler Ph.D.||No Relationships||Co-Founder and Chief Scientific Officer||--|
|View More Key Executives|
InCarda Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|John S. Patton Ph.D., MSc, MBA||31 Relationships||Dance BioPharm Inc.||68|
|Raymond John Lipicky M.D.||53 Relationships||InCarda Therapeutics, Inc.||--|
|David R. Savello Ph.D.||38 Relationships||Pappas Capital, LLC||70|
|Robert Hamlin DVM, Ph.D.||7 Relationships||PhaseBio Pharmaceuticals, Inc.||--|
|Chet Leach Ph.D., D.A.B.T.||7 Relationships||IR Biosciences Holdings Inc.||--|
InCarda Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.